Vitaspring Biomedical Co. Ltd.
VSBC· OTC
VSBCVitaspring Biomedical Co. Ltd.
Filed Jun 17, 2026 · 10-K · 137 days after period end · 0001640334-26-001082
derived · Computed from the longer spans the company filed.
| Metric | Q4 2026dderived from reported figures | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | — |
| Net Income | -$81.46K | -$143.14K | -$225.40K | -$4.16M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vitaspring Biomedical Co. Ltd. · CIK 1697884 · Engraved from SEC EDGAR
ended Jan 31, 2026 · filed Jun 17, 2026 · 137 d after period end
